Clinical Trial Update: Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard Treatment for First-line Extensive-stage Small Cell Lung Cancer in the Cachexia Phase [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating adding nano-crystalline megestrol acetate to standard therapy versus standard therapy alone as first-line treatment for extens…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Cachexia
• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Megestrol acetate (megestrol acetate)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Extensive-stage Small Cell Lung Cancer (ES-SCLC), The Pre-cachexia or Cachexia Patients Who Have Not Received Systemic Treatment and Are Not Eligible for Curative Therapy | Phase 3 | Status: NOT_YET_RECRUITING